Honeywell International INC Has Boosted Its Johnson & Johnson (JNJ) Stake by $6.49 Million

Johnson & Johnson (NYSE:JNJ) LogoInvestors sentiment increased to 0.97 in 2018 Q2. Its up 0.04, from 0.93 in 2018Q1. It improved, as 36 investors sold JNJ shares while 806 reduced holdings. 114 funds opened positions while 704 raised stakes. 1.84 billion shares or 8.07% more from 1.71 billion shares in 2018Q1 were reported. Honeywell holds 2.41% or 330,700 shares in its portfolio. Indiana Investment owns 15,025 shares or 0.87% of their US portfolio. Ny State Common Retirement Fund has 7.42 million shares for 1.12% of their portfolio. Mycio Wealth Lc has 36,600 shares for 0.46% of their portfolio. Lakeview Capital Llc has invested 1.09% of its portfolio in Johnson & Johnson (NYSE:JNJ). Stock Yards National Bank & Communication reported 154,198 shares. Clinton Group has invested 0% in Johnson & Johnson (NYSE:JNJ). Horan Capital Lc stated it has 197 shares or 0.02% of all its holdings. Canandaigua National Bank & Trust & Tru holds 2.95% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 126,737 shares. Cls Invests Ltd Liability Company owns 4,015 shares for 0.02% of their portfolio. Anchor Cap Advsr Ltd Co invested 0.79% in Johnson & Johnson (NYSE:JNJ). Psagot House Limited invested 0.01% of its portfolio in Johnson & Johnson (NYSE:JNJ). Amica Retiree owns 15,246 shares for 1.61% of their portfolio. Harvest Cap Mgmt, New Hampshire-based fund reported 28,654 shares. Hall Laurie J Trustee invested 3.54% of its portfolio in Johnson & Johnson (NYSE:JNJ).

Since August 27, 2018, it had 0 insider buys, and 6 selling transactions for $55.00 million activity. Sneed Michael E also sold $4.41M worth of Johnson & Johnson (NYSE:JNJ) on Friday, November 23. Duato Joaquin sold $5.77M worth of Johnson & Johnson (NYSE:JNJ) on Wednesday, November 7. 7,899 Johnson & Johnson (NYSE:JNJ) shares with value of $1.08 million were sold by Kapusta Ronald A.

Honeywell International Inc increased its stake in Johnson & Johnson (JNJ) by 19.34% based on its latest 2018Q2 regulatory filing with the SEC. Honeywell International Inc bought 53,600 shares as the company’s stock rose 13.64% with the market. The institutional investor held 330,700 shares of the major pharmaceuticals company at the end of 2018Q2, valued at $40.13 million, up from 277,100 at the end of the previous reported quarter. Honeywell International Inc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $391.33 billion market cap company. The stock decreased 0.08% or $0.12 during the last trading session, reaching $145.91. About 11.57M shares traded or 62.52% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 5.07% since December 7, 2017 and is uptrending. It has underperformed by 10.55% the S&P500.

Honeywell International Inc, which manages about $1.66 billion US Long portfolio, decreased its stake in Costco Wholesale Corp New (NASDAQ:COST) by 31,300 shares to 108,800 shares, valued at $22.74 million in 2018Q2, according to the filing. It also reduced its holding in Amazon Com Inc (NASDAQ:AMZN) by 2,600 shares in the quarter, leaving it with 31,600 shares, and cut its stake in Alexion Pharmaceuticals Inc (NASDAQ:ALXN).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Bizjournals.com which released: “Houston cancer pharma co. begins Phase I trials after $6M Series B – Houston Business Journal” on December 06, 2018, also Seekingalpha.com with their article: “Johnson & Johnson (JNJ) Management Presents at Citi’s 2018 Global Healthcare Conference (Transcript) – Seeking Alpha” published on December 05, 2018, Fool.com published: “Top Biotech Stocks to Watch at ASH 2018 – Motley Fool” on December 01, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Investorplace.com and their article: “7 Dividend Titans Trading Like Growth Stocks – Investorplace.com” published on December 06, 2018 as well as Fool.com‘s news article titled: “Why Johnson & Johnson’s Up 3% So Far in 2018 – Motley Fool” with publication date: November 15, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 6 analysts covering Johnson & Johnson (NYSE:JNJ), 2 have Buy rating, 0 Sell and 4 Hold. Therefore 33% are positive. Johnson & Johnson has $153 highest and $129 lowest target. $146.20’s average target is 0.20% above currents $145.91 stock price. Johnson & Johnson had 7 analyst reports since June 12, 2018 according to SRatingsIntel. Citigroup maintained Johnson & Johnson (NYSE:JNJ) on Monday, October 22 with “Neutral” rating. Morgan Stanley maintained Johnson & Johnson (NYSE:JNJ) on Thursday, October 11 with “Equal-Weight” rating. The company was maintained on Wednesday, October 17 by Credit Suisse. The stock has “Buy” rating by Credit Suisse on Tuesday, June 12. The firm earned “Neutral” rating on Thursday, July 12 by Goldman Sachs. The rating was maintained by Raymond James with “Outperform” on Wednesday, October 17.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.